Multiplex screening of 422 candidate serum biomarkers in bladder cancer patients identifies syndecan-1 and macrophage colony-stimulating factor 1 as prognostic indicators

Richard T. Bryan, Naheema S. Gordon, Ben Abbotts, Maurice P. Zeegers, Kar K. Cheng, Nicholas D. James, Douglas G. Ward*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)S657-S665
Number of pages9
JournalTranslational Cancer Research
Volume6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • Bladder cancer
  • serum
  • biomarker
  • prognosis
  • syndecan-1
  • CIRCULATING TUMOR-CELLS
  • UROTHELIAL CARCINOMA
  • POOR SURVIVAL
  • LUNG-CANCER
  • M-CSF
  • VALIDATION
  • CYSTECTOMY
  • NECTIN-4
  • MARKERS
  • EPCAM

Cite this